Dies ist eine HTML Version eines Anhanges der Informationsfreiheitsanfrage 'The Vaccines Procurement Steering Committee & the Joint Negotiation Team'.

From:
To:
 (SJ)
modernatx.com
Cc:
@modernatx.com; 
@modernatx.com; 
@modernatx.com; 
@modernatx.com;
@modernatx.com;
 (SANTE); 
@modernatx.com; 
@aemps.es;
@igf finances.gouv.fr; 
 (SANTE); 
 (SG-RECOVER); 
 (SJ); 
(SJ); 
@regeringskansliet se; 
 (SG); GALLINA Sandra (SANTE)
Subject:
RE: Moderna - APA Draft Contract
Date:
dimanche 22 novembre 2020 19:28:54
Attachments:
image001.png
Hi 
 
Thank you for your email.  I speak subject to Moderna’s review and comment, but our intention is tha
 
 
Please let me know if you have any questions or would like to discuss further.
 
Kind regards,
 
From: 
@ec.europa.eu> 
Sent: Sunday, November 22, 2020 12:26 PM
To: 
@modernatx.com
Cc
@modernatx.com;
@modernatx.com; 
@modernatx.com;
@modernatx.com; 
@modernatx.com; 
@ec.europa.eu;
@modernatx.com; 
@aemps.es;
@igf.finances.gouv.fr; 
@ec.europa.eu; J
@ec.europa.eu;
@ec.europa.eu; 
@ec.europa.eu; 
@regeringskansliet.se;
@ec.europa.eu;
@ec.europa.eu
Subject: RE: Moderna - APA Draft Contrac
 
Dear colleagues,
 
While reading the contract one question for clarification popped up. 
 
Many thanks for clarifying.
 
Best regards, 
 
 
 
From: 
 (SJ) 
Sent: Sunday, November 22, 2020 4:19 PM
To: 
@modernatx.com
Cc: 
@modernatx.com; 
@modernatx.com; 
@modernatx.com;
@modernatx.com; 
@modernatx.com; 
 (SANTE)
@ec.europa.eu>; 
@modernatx.com; 
@aemps.es; 
@igf.finances.gouv.fr; 
 (SANTE)
@ec.europa.eu>; 
 (SG-RECOVER) 
@ec.europa.eu>;
 (SJ) 
@ec.europa.eu>; 
 (SJ)
@ec.europa.eu>; 
@regeringskansliet.se; 
(SG)
@ec.europa.eu>; GALLINA Sandra (SANTE) 
@ec.europa.eu>
Subject: RE: Moderna - APA Draft Contract
 
Many thanks 
I acknowledge receipt. We will review and come back to you asap subject of course to Moderna’s
internal review, which is well noted. Coming back to 
point on calculating the precise euro sum on the basis of
dollars for the final contract, I have given it further thought. Subject to checking with our 
colleagues, I believe
we could already fix the reference period for the purposes 





Following the constructive meeting a moment ago, please find enclosed a template for the annex on
the
. Please go as far in detail as you consider reasonably possible.
 
Best regards
 
From: 
 
Sent: Wednesday, November 18, 2020 4:01 PM
To: 
 (SJ) 
@ec.europa.eu>;
@modernatx.com
Cc: 
@modernatx.com; 
@modernatx.com;
@modernatx.com;
@modernatx.com;
@modernatx.com; 
 (SANTE) <
@ec.europa.eu>;
@modernatx.com; 
@aemps.es; 
@igf.finances.gouv.fr; 
 (SANTE)
@ec.europa.eu>; 
 (SG-RECOVER)
@ec.europa.eu>; 
 (SJ)
@ec.europa.eu>; 
 (SJ) <
@ec.europa.eu>;
@regeringskansliet.se; 
 (SG) 
@ec.europa.eu>
Subject: RE: Moderna - APA Draft Contract
 
All:
 
Further to my earlier email, we would like to provide you with a list of the
incurred by Moderna to date for the establishment and
acceleration of the manufacturing and supply of mRNA-1273 for the Commission and the
Member States:
 
 
We look forward to speaking with you today.
 
Kind regards,
 
From: 
 
Sent: Wednesday, November 18, 2020 7:49 AM
To: 
@ec.europa.eu
@modernatx.com
Cc: 
@modernatx.com; 
@modernatx.com;
@modernatx.com;
@modernatx.com;
@modernatx.com; 
@ec.europa.eu;
@modernatx.com; 
@aemps.es; 
@igf.finances.gouv.fr;
@ec.europa.eu;
@ec.europa.eu;
@ec.europa.eu; 
@ec.europa.eu
Subject: RE: Moderna - APA Draft Contract
 
Hi all:
 
Please find attached high-level issues list for our discussion today.  Please note that this list is
focused on the most substantive business issues, and we will propose additional revisions in
writing in our next draft.
 
We look forward to speaking with you.
 
Kind regards,

 
 
From: 
ec.europa.eu> 
Sent: Monday, November 16, 2020 12:41 PM
To: 
@modernatx.com
Cc: 
@modernatx.com; 
@modernatx.com;
@modernatx.com; J
@modernatx.com;
@modernatx.com; 
@ec.europa.eu;
@modernatx.com; 
@aemps.es; 
@igf.finances.gouv.fr;
@ec.europa.eu; J
@ec.europa.eu;
@ec.europa.eu; 
@ec.europa.eu
Subject: RE: Moderna - APA Draft Contract
 
***EXTERNAL***
Dear all,
 
Please find enclosed our TCs and comments on your latest draft. Because of structural changes
and the number of comments, we have not had the time to adjust any cross references, which
would need to be done only once the draft is more stable. However, from no on it would be
fundamental for the process if we can work on a joint word document where agreement on a
given text is clearly indicated in the comments or comments are provided on comments. We
could then clean the draft during or on the basis of a call. Any structural changes should be as
limited as possible simply to keep track on each other’s positions. Once the draft is more
stable, we can consider whether further structural changes are necessary. In the current home
office conditions it is very challenging if there is a need to go back and forth between a TC pdf
and a clean word document.
 
Please note that this is work in progress on our side too so I cannot exclude that we need to
still revisit some more detailed issues as we have not managed to double check everything. But
this can be done quickly once the draft is more advanced.
 
Looking forward to discussing over a call.
 
Best, 
 
 
 
From: 
 
Sent: Thursday, November 12, 2020 7:08 PM
To: 
 (SJ) 
 (SJ)
 (SJ)
 (COMP)
 (SANTE)
@igf.finances.gouv.fr;
@aemps.es; 
 (SANTE) 
@ec.europa.eu>
Cc: 
@modernatx.com>;
@modernatx.com>
@modernatx.com>; 
@modernatx.com>; 
@modernatx.com>; 
@modernatx.com>;
@modernatx.com>;
Subject: Moderna - APA Draft Contract
 
 
All:
 
On behalf of Moderna, please find attached a revised draft of the Advance Purchase
Agreement in clean and redline comparison formats.  The redline comparison is marked to
reflect changes from the draft that 
 circulated on 9 November.  As you will note, we have
included annotated footnotes in the revised draft, which include areas where we would
appreciate the opportunity to discuss with your team prior to providing draft language for your